Craft

PharmaTher Holdings

Stock Price

$0.2

2024-10-29

Market Capitalization

$13.5 M

2024-10-29

PharmaTher Holdings Summary

Company Summary

Overview
PharmaTher Holdings is a biotech company focused on the research, development, and commercialization of novel uses and pain disorders. It offers focused on the research, development, and commercialization of specialty ketamine pharmaceuticals for mental health, neurological and pain disorders, anesthesia, and procedural sedation.
Type
Public
Status
Active
Founded
2019
Website
https://www.pharmather.com
Cybersecurity rating
Sectors

Table of Contents

PharmaTher Holdings Financials

Summary Financials

Net income (Q2, 2026)
($C249.0K)
Cash (Q2, 2026)
$C704.0K
EBIT (Q2, 2026)
($C249.0K)

Footer menu